In cervical squamous cell carcinoma, CD109 expression enhanced aggressiveness and maintained cancer stemness properties through the EGFR-STAT3 signaling cascade [13], suggesting the potential role of CD109 as a diagnostic cancer marker and therapeutic target. The gene discussed is EGFR; the disease is cancer.